Not applicableUnknownNCT04126915What this trial is testingPrecise Therapy for mCRPC Patients Through Whole Exome Sequencing(PTtWES)Who this might be right forCastration-Resistant Prostatic Cancer Yinghao Sun 200
Testing effectiveness (Phase 2)Ended earlyNCT02844582What this trial is testingCabazitaxel and Prednisone in Treating Patients With Metastatic Hormone-Resistant Prostate CancerWho this might be right forHormone-Resistant Prostate CancerStage IV Prostate Adenocarcinoma University of California, Davis 2
Large-scale testing (Phase 3)Study completedNCT03388346What this trial is testing68Ga PSMA in Preprostatectomy PatientsWho this might be right forProstate CancerProstatic NeoplasmProstatic Neoplasms, Castration-Resistant+1 more Michael Graham PhD, MD 22
Post-approval studies (Phase 4)Study completedNCT02441894What this trial is testingCombination of Cabazitaxel With Prednisolone With Primary Prophylaxis With PEG-G-CSF in Treatment of Patients With Prostate CancerWho this might be right forProstate Cancer Sanofi 21
Testing effectiveness (Phase 2)Study completedNCT02711956What this trial is testingZEN003694 in Combination With Enzalutamide in Patients With Metastatic Castration-Resistant Prostate CancerWho this might be right forMetastatic Castration-Resistant Prostate Cancer Zenith Epigenetics 75
Early research (Phase 1)Ended earlyNCT04634344What this trial is testingAssess the Safety, Tolerability, PK and Anti-tumor Efficacy of DZD2269 in Patients With MCRPCWho this might be right forMetastatic Castration Resistant Prostate Cancer Dizal Pharmaceuticals 16
Not applicableUnknownNCT05188911What this trial is testingAnalysis of Next Generation PET and Liquid Biopsy to Monitor mCRPC Treated With Abiraterone: ANGELA TrialWho this might be right forProstate CancerCastration-resistant Prostate CancerMetastatic Disease Fudan University 30
Testing effectiveness (Phase 2)Study completedNCT01695044What this trial is testingPSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)Who this might be right forProstate Cancer Progenics Pharmaceuticals, Inc. 119
Not applicableNot Yet RecruitingNCT07587814What this trial is testingImpact of Body Composition on Dosimetry of 177Lu-PSMA Radioligand TherapyWho this might be right forCarcinomaCastration Resistant Prostatic Neoplasms Centre Henri Becquerel 100
Testing effectiveness (Phase 2)Study completedNCT02601014What this trial is testingBiomarker-Driven Therapy With Nivolumab and Ipilimumab in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Expressing AR-V7Who this might be right forProstate CancerRecurrent Prostate CarcinomaStage IV Prostate Adenocarcinoma Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 32
Large-scale testing (Phase 3)Ended earlyNCT01981707What this trial is testingF-choline PET in Early Response Assessment for Castration Resistant Prostatic CancerWho this might be right forCastration-resistant Prostate Cancer University Hospital, Grenoble 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT05011188What this trial is testingFOR46 in Combination With Enzalutamide in Patients With Metastatic Castration Resistant Prostate CancerWho this might be right forMetastatic Castration-resistant Prostate CancerProstate Cancer Rahul Aggarwal 44
Testing effectiveness (Phase 2)Study completedNCT03414034What this trial is testingOnvansertib in Combination With Abiraterone and Prednisone in Adult Patients With Metastatic Castration-Resistant Prostate CancerWho this might be right forMetastatic Castration-Resistant Prostate Cancer Cardiff Oncology 72
Testing effectiveness (Phase 2)Study completedNCT03570619What this trial is testingImmunotherapy in Patients With Metastatic Cancers and CDK12 MutationsWho this might be right forMetastatic Castration Resistant Prostate CancerMetastatic CancerSolid Tumor University of Michigan Rogel Cancer Center 56
Very early researchStudy completedNCT01804712What this trial is testingRituximab Neoadjuvant Therapy in Patients With Prostate Cancer Scheduled to Undergo Radical ProstatectomyWho this might be right forProstate Cancer Christopher Kane 8
Testing effectiveness (Phase 2)Ended earlyNCT02640534What this trial is testingInvestigation of Metformin in Patients With Castration Resistant Prostate Cancer in Combination With Enzalutamide vs. Enzalutamide AloneWho this might be right forCancer of the ProstateProstate Cancer Swiss Cancer Institute 169
Early research (Phase 1)Study completedNCT04521361What this trial is testingAssess How Radium-223 Distributes in the Body of Patients With Prostate Cancer Which Spread to the BonesWho this might be right forBone Metastatic Castration-resistant Prostate Cancer Bayer 46
Testing effectiveness (Phase 2)Study completedNCT01487720What this trial is testingGEMOX in Docetaxel-Refractory Castration-Resistant Prostate CancerWho this might be right forProstate Cancer Asan Medical Center 33
Testing effectiveness (Phase 2)Study completedNCT01254513What this trial is testingFeasibility of a Chemotherapy With Docetaxel-Prednisone for Castration-resistant Metastatic Prostate Cancer Elderly PatientsWho this might be right forProstate Cancer UNICANCER 66
Testing effectiveness (Phase 2)Active Not RecruitingNCT03012321What this trial is testingAbiraterone/Prednisone, Olaparib, or Abiraterone/Prednisone + Olaparib in Patients With Metastatic Castration-Resistant Prostate Cancer With DNA Repair DefectsWho this might be right forProstate Cancer Metastatic Castration-ResistantAbnormal DNA RepairMetastatic Prostate Carcinoma+1 more Northwestern University 70